Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Polymorphisms at 1q32, 8q24, and 17q22 loci are associated with nonsyndromic cleft lip with or without cleft palate risk in the Slovak population.

Salagovic J, Klimcakova L, Zabavnikova M, Behunova J, Hudakova T, Fedeles J, Molnarova A, Podracka L.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):152-157. doi: 10.5507/bp.2017.009. Epub 2017 Mar 30.

2.

Association between TCF7L2 Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide.

Javorský M, Babjaková E, Klimčáková L, Schroner Z, Zidzik J, Stolfová M, Salagovič J, Tkáč I.

Int J Endocrinol. 2013;2013:374858. doi: 10.1155/2013/374858. Epub 2013 Feb 20.

3.

Closed tube method for rapid screening of IL28B polymorphisms involved in response to hepatitis C treatment.

Habalová V, Klimčáková L, Židzik J, Vasovčák P, Kristian P, Valková I, Schréter I, Šalagovič J.

Mol Cell Probes. 2012 Aug;26(4):159-63. doi: 10.1016/j.mcp.2012.04.001. Epub 2012 Apr 10.

PMID:
22521237
4.

KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.

Javorsky M, Klimcakova L, Schroner Z, Zidzik J, Babjakova E, Fabianova M, Kozarova M, Tkacova R, Salagovic J, Tkac I.

Eur J Intern Med. 2012 Apr;23(3):245-9. doi: 10.1016/j.ejim.2011.10.018. Epub 2011 Nov 26.

PMID:
22385882
5.

Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.

Sivonova MK, Dobrota D, Matakova T, Dusenka R, Grobarcikova S, Habala V, Salagovic J, Tajtakova M, Pidanicova A, Valansky L, Lachvacs L, Kliment J Jr, Nagy V, Kliment J.

Neoplasma. 2012;59(1):79-84.

PMID:
22103900
6.

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas.

Schroner Z, Dobrikova M, Klimcakova L, Javorsky M, Zidzik J, Kozarova M, Hudakova T, Tkacova R, Salagovic J, Tkac I.

Med Sci Monit. 2011 Jul;17(7):CR392-6.

7.

Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population.

Salagovič J, Klimčáková L, Ilenčíková D, Kafková A.

Med Oncol. 2012 Jun;29(2):1173-8. doi: 10.1007/s12032-011-9925-9. Epub 2011 Apr 8.

PMID:
21476145
8.

[Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population].

Dobríková M, Javorský M, Habálová V, Klimcáková L, Kozárová M, Zidzik J, Halusková J, Salagovic J, Tkác I.

Vnitr Lek. 2011 Feb;57(2):155-8. Slovak.

PMID:
21416855
9.

Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.

Klimčáková L, Habalová V, Sivoňová M, Nagy V, Šalagovič J, Židzik J.

Mol Biol Rep. 2011 Feb;38(2):1287-93. doi: 10.1007/s11033-010-0228-6. Epub 2010 Jun 22.

PMID:
20568013
10.

Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population.

Kozarova M, Javorsky M, Stancakova A, Dobrikova M, Habalova V, Klimcakova L, Zidzik J, Haluskova J, Salagovic J, Tkac I.

Bratisl Lek Listy. 2010;111(3):150-2.

PMID:
20437825
11.

Gene polymorphisms of renin angiotensin system and serotonin transporter gene in patients with vasovagal syncope.

Mudrakova K, Mitro P, Salagovic J, Habalova V, Kirsch P, Tkac I.

Bratisl Lek Listy. 2009;110(2):73-6.

PMID:
19408837
12.

Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.

Mokry M, Joppa P, Slaba E, Zidzik J, Habalova V, Kluchova Z, Micietova L, Rozborilova E, Salagovic J, Tkacova R.

Med Sci Monit. 2008 Aug;14(8):CR392-8.

PMID:
18667995
13.

Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population.

Zidzik J, Slabá E, Joppa P, Kluchová Z, Dorková Z, Skyba P, Habalová V, Salagovic J, Tkácová R.

Croat Med J. 2008 Apr;49(2):182-91.

14.

Influence of PAHs in ambient air on chromosomal aberrations in exposed subjects: international study - EXPAH.

Zidzik J, Kalina I, Salagovic J, Sram RJ, Rössner P, Popov T, Farmer PB.

Mutat Res. 2007 Jul 1;620(1-2):41-8. Epub 2007 Mar 3.

PMID:
17391715
15.

Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.

Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I.

Physiol Res. 2006;55(5):483-90. Epub 2005 Dec 12.

16.

A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer.

Habalová V, Salagovic J, Kalina I, Stubna J.

Neoplasma. 2005;52(5):364-8.

PMID:
16151580
17.

The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD.

Tkácová R, Joppa P, Stancák B, Salagovic J, Misíková S, Kalina I.

Wien Klin Wochenschr. 2005 Mar;117(5-6):210-4.

PMID:
15875760
18.

Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.

Javorský M, Kozárová M, Salagovic J, Tkác I.

Physiol Res. 2006;55(1):55-62. Epub 2005 Apr 26.

19.

[Renin-angiotensin system: molecular biology].

Zidzik J, Salagovic J, Fleischer B, Kalina I.

Cesk Fysiol. 2004;53(4):142-51. Review. Slovak.

PMID:
15704738
20.
21.

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.

Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Coutelle C, Daly AK, Muzi G, Dolzan V, Duzhak TG, Farker K, Golka K, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Katoh T, Kihara M, Ono-Kihara M, Kim H, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, London S, Manni JJ, Maugard CM, Morgan GJ, Morita S, Nazar-Stewart V, Kristensen VN, Oda Y, Parl FF, Peters WH, Rannug A, Rebbeck T, Pinto LF, Risch A, Romkes M, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnett D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Zheng W, Pedotti P, Taioli E.

Int J Cancer. 2004 Jun 10;110(2):266-70.

22.

Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer.

Tkácová R, Salagovic J, Ceripková M, Tkác I, Stubna J, Kalina I.

Wien Klin Wochenschr. 2004 Feb 28;116(4):131-4.

PMID:
15038404
23.

Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.

Tkác I, Salagovic J, Kozárová M, Javorský M, Tkácová R, Kalina I.

Wien Klin Wochenschr. 2003 Dec 15;115(23):835-9.

PMID:
14740347
24.

CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.

Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E.

Carcinogenesis. 2003 May;24(5):875-82.

PMID:
12771031
25.

Interaction between angiotensin-converting enzyme genotype and glycaemic control influences lipoprotein levels in type 2 diabetes mellitus.

Tkác I, Salagovic J, Kozárová M, Rosolová H, Molcányiová A, Mosorjáková D, Chleborádová M, Kalina I.

Wien Klin Wochenschr. 2003 Jan 31;115(1-2):36-40.

PMID:
12658909
26.

Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients.

Biros E, Kalina I, Kohút A, Bogyiová E, Salagovic J, Sulla I.

Physiol Res. 2002;51(1):59-64.

27.

Polymorphism of the p53 gene within the codon 72 in lung cancer patients.

Biros E, Kalina I, Biros I, Kohut A, Bogyiová E, Salagovic J, Stubna J.

Neoplasma. 2001;48(5):407-11.

PMID:
11845987
28.

Metabolic gene polymorphism frequencies in control populations.

Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stücker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E.

Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1239-48.

29.

[Genetic polymorphism of enzymes metabolizing xenobiotics as a factor in susceptibility to tumor development].

Salagovic J, Kalina I, Dudas M.

Bratisl Lek Listy. 2000;101(9):512-21. Review. Slovak.

PMID:
11187056
30.

Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer.

Biros E, Kalina I, Kohút A, Stubna J, Salagovic J.

Lung Cancer. 2001 Feb-Mar;31(2-3):157-62.

PMID:
11165394
31.

p53 single nucleotide polymorphisms and bladder cancer.

Biroš E, Kalina I, Salagovic J, Habalová V, Hriv ák M, Valanský L.

Neoplasma. 2000;47(5):303-6.

PMID:
11130248
32.

The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer.

Salagovic J, Kalina I, Habalová V, Hrivnák M, Valanský L, Biros E.

Physiol Res. 1999;48(6):465-71.

33.

Reciprocal adaptive response of human peripheral lymphocytes induced by bleomycine or gamma rays.

Kalina I, Brezáni P, Habalová V, Kohút A, Biros E, Némethová G, Salagovic J.

Physiol Res. 1999;48(2):171-4.

34.

Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.

Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E.

Neoplasma. 1998;45(5):312-7.

PMID:
9921921
35.

Cytogenetic monitoring in coke oven workers.

Kalina I, Brezáni P, Gajdosová D, Binková B, Salagovic J, Habalová V, Mracková G, Dobiás L, Srám RJ.

Mutat Res. 1998 Sep 1;417(1):9-17.

PMID:
9729241
36.

The cell cycle positions influence DNA migration as measured with the alkaline comet assay in stimulated human lymphocytes.

Salagovic J, Maes A, Van Gorp U, Verschaeve L, Kalina I.

Folia Biol (Praha). 1997;43(2):79-82.

PMID:
9158955
37.
38.
39.

[Mutagenic activity of urine of patients with psoriasis treated with pharmaceutical black coal tar].

Gardosová D, Kalina I, Hejj F, Mezencevová V, Salagovic J, Némethová G.

Cas Lek Cesk. 1994 Aug 1;133(15):463-6. Slovak.

PMID:
8082111

Supplemental Content

Loading ...
Support Center